Xiaogang Li
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 5
- Cancer, Lipids, and Metabolism 4
- Genetics top 10%
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 6
-
- RNA modifications and cancer 6
- Neurology top 10%
- Amyotrophic Lateral Sclerosis Research 5
-
- Gastric Cancer Management and Outcomes 5
- Co-authors
- Zhiqiang LiuShanmiao GouZhun YanJianping XuChunyou WangXinyu TanYe ZengTong Li
- Cited by
- Cancer ResearchGeneticsOncology
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaogang Li
63 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 298
- Genetics 131
- Oncology 242
- Molecular Biology 499
- Neurology 101
Countries citing papers authored by Xiaogang Li
This map shows the geographic impact of Xiaogang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Li more than expected).
Fields of papers citing papers by Xiaogang Li
This network shows the impact of papers produced by Xiaogang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Li. The network helps show where Xiaogang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaogang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 37 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 6 | |
| 8 | Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4 | 2020 | 6 |
| 9 | 2019 | 14 | |
| 10 | 2018 | 1 | |
| 11 | 2017 | 67 | |
| 12 | 2017 | 12 | |
| 13 | 2016 | 9 | |
| 14 | 2016 | 11 | |
| 15 | 2015 | 6 | |
| 16 | Correlation of E-selectin gene polymorphisms with risk of ischemic stroke: A meta-analysis | 2011 | 7 |
| 17 | Intravenous thrombolysis for acute ischemic stroke. | 2009 | 1 |
| 18 | 2009 | 75 | |
| 19 | 2008 | 1 | |
| 20 | Expression of X-linked inhibitor of apoptosis in pancreatic carcinoma tissues and its relationship to chemoresistance | 2006 | 1 |
About Xiaogang Li
Xiaogang Li is a scholar working on Cancer Research, Oncology and Genetics, having authored 73 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), RNA modifications and cancer (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers), Gastric Cancer Management and Outcomes (5 papers), MicroRNA in disease regulation (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (298 citations), Genetics (131 citations) and Oncology (242 citations). Xiaogang Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhiqiang Liu, Shanmiao Gou, Zhun Yan, Jianping Xu, Chunyou Wang, Xinyu Tan, Ye Zeng, Tong Li, Ashok R. Asthagiri and Leor Zach. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.